Trial Profile
MoTriColor: A Phase II Study of Vinorelbine in Advanced BRAF-like Colon Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Sep 2022
Price :
$35
*
At a glance
- Drugs Vinorelbine (Primary)
- Indications Adenocarcinoma; Colon cancer
- Focus Therapeutic Use
- Acronyms EORTC1616; MoTriColor
- 04 Apr 2018 New trial record